Home

jalea Cuarto Lugar de nacimiento ct26 mouse model Premedicación Extranjero Baya

Anti‑tumor effects of an aqueous extract of <em>Ecklonia cava</em> in  BALB/cKorl syngeneic mice using colon carcinoma CT26 cells
Anti‑tumor effects of an aqueous extract of <em>Ecklonia cava</em> in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells

Synergistic and low adverse effect cancer immunotherapy by immunogenic  chemotherapy and locally expressed PD-L1 trap | Nature Communications
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap | Nature Communications

Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic  Tumor Models Using Multi-Color Flow Cytometry Assays
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays

CT26-Luc: An orthotopic murine model of colon cancer: implications for  immuno-oncology studies
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies

Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and  Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer | Cancer  Genomics & Proteomics
Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer | Cancer Genomics & Proteomics

Antitumor Activities of Immune Costimulatory Molecules of TNF Superfamily  in Colorectal and Lung Cancers
Antitumor Activities of Immune Costimulatory Molecules of TNF Superfamily in Colorectal and Lung Cancers

Functional & phenotypic analysis of murine CAR-M CAR-M shrink tumors,  improve overall survival, reprogram the TME, and prime
Functional & phenotypic analysis of murine CAR-M CAR-M shrink tumors, improve overall survival, reprogram the TME, and prime

Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic  tumors of three BALB/c substrains | Laboratory Animal Research | Full Text
Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains | Laboratory Animal Research | Full Text

Frontiers | Low-dose immunogenic chemotherapeutics promotes immune  checkpoint blockade in microsatellite stability colon cancer
Frontiers | Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer

Dendritic cell paucity in mismatch repair–proficient colorectal cancer  liver metastases limits immune checkpoint blockade efficacy | PNAS
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy | PNAS

New In Vivo Syngeneic Subcutaneous CT26 Colon Tumor Model Shuttle Session -  by Explicyte Immuno-Oncology
New In Vivo Syngeneic Subcutaneous CT26 Colon Tumor Model Shuttle Session - by Explicyte Immuno-Oncology

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in  preclinical breast and colon model with independent regulatory T cells  response - ScienceDirect
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect

CT-26 Syngeneic Model - TD2 Precision Oncology
CT-26 Syngeneic Model - TD2 Precision Oncology

Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020  - Cancer Science - Wiley Online Library
Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020 - Cancer Science - Wiley Online Library

Radiation dose and schedule influence the abscopal effect in a bilateral murine  CT26 tumor model - ScienceDirect
Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model - ScienceDirect

Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020  - Cancer Science - Wiley Online Library
Immunogenic chemotherapy in two mouse colon cancer models - Taniura - 2020 - Cancer Science - Wiley Online Library

Cells | Free Full-Text | Intratumoral Administration of High-Concentration  Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and  Survival in CT26 Tumor-Bearing Mice
Cells | Free Full-Text | Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice

mAb146 significantly inhibited tumor growth in CT-26 syngeneic model.... |  Download Scientific Diagram
mAb146 significantly inhibited tumor growth in CT-26 syngeneic model.... | Download Scientific Diagram

Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic  Tumor Models Using Multi-Color Flow Cytometry Assays
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays

Study design and methods. Mice were subcutaneously inoculated with CT26...  | Download Scientific Diagram
Study design and methods. Mice were subcutaneously inoculated with CT26... | Download Scientific Diagram

sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... |  Download Scientific Diagram
sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... | Download Scientific Diagram

SubQperior Tumor Models - Reaction Biology
SubQperior Tumor Models - Reaction Biology

MC38 Syngeneic Mouse Model - Altogen Labs
MC38 Syngeneic Mouse Model - Altogen Labs

CT26 Xenograft Model | Xenograft Services
CT26 Xenograft Model | Xenograft Services

Reduced growth of the CT26 colon carcinoma in syngeneic MIF 2/2 mice.... |  Download Scientific Diagram
Reduced growth of the CT26 colon carcinoma in syngeneic MIF 2/2 mice.... | Download Scientific Diagram

In vivo growth suppression of CT-26 mouse colorectal cancer cells by  adenovirus-expressed small hairpin RNA specifically targeting thymosin  beta-4 mRNA | Cancer Gene Therapy
In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA | Cancer Gene Therapy

Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for  Colorectal Carcinoma
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma

CT26 Tumor Model | Melior Discovery
CT26 Tumor Model | Melior Discovery